Evommune, Inc. (EVMN) Operating income 2024–2025
Evommune, Inc. (EVMN) annual operating income history from SEC filings — each fiscal year as reported.
-$81.1MFY2025 · since FY2024: -$70.0M → -$81.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$81.1M | -15.8% |
| FY2024 | -$70.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating marginEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →